Guardant Health Newsroom

Guardant Health (NASDAQ:GH Shareholders Incur Further Losses as Stock Declines 8.9% This Week, Taking Three-year Losses to 68%

Simply Wall StDec 22 07:42 ET

Guardant Health Enters Partnership With MiBA

TipRanksDec 20 08:15 ET

Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care

BusinesswireDec 20 08:05 ET

Express News | Cota and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development With Real-World Clinicogenomic Data and AI Analytics

ReutersDec 19 06:00 ET

COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development With Real-World Clinicogenomic Data and AI Analytics

BusinesswireDec 19 06:00 ET

Express News | Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer

ReutersDec 18 08:05 ET

Insider Sale: Director at $GH (GH) Sells 2,320 Shares

Quiver QuantitativeDec 16 18:16 ET

Express News | Guardant Health Inc : Guggenheim Raises Target Price to $40 From $36

ReutersDec 16 07:14 ET

Manulife Singapore Partners With Guardant Health to Provide Cancer Treatments

MT NewswiresDec 10 22:58 ET

Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium

BusinesswireDec 9 08:05 ET

Investors in Guardant Health (NASDAQ:GH) From Three Years Ago Are Still Down 61%, Even After 8.6% Gain This Past Week

Yahoo FinanceDec 5 09:46 ET

Stocks With Improving and Deteriorating 'TechniGrade' by Piper Sandler

Seeking AlphaDec 3 13:52 ET

Express News | Guardant Health Says Jury Unanimously Rejected All Of Natera's Counterclaims And Awarded $292.5M To Company, Including $175.5M In Punitive Damages

BenzingaNov 25 17:23 ET

Express News | Guardant Health Shares Are Trading Higher After a Jury Issued a Decision in the Company's Favor Regarding a False Advertising Case Filed by Natera Concerning Statements Made About Guardant's Reveal Test

BenzingaNov 25 15:58 ET

Natera Issues Statement On Guardant Health Litigation; Says "A Jury Issued A Decision In Guardant's Favor. We Disagree With This Decision And Will Ask The Court To Overturn It"

BenzingaNov 25 15:53 ET

Express News | Natera Issues Statement on Guardant Health Litigation

ReutersNov 25 15:51 ET

Is There Now An Opportunity In Guardant Health, Inc. (NASDAQ:GH)?

Simply Wall StNov 25 05:59 ET

Guardant Health, Inc. (GH): Among the Most Promising Cancer Stocks According to Hedge Funds

Yahoo FinanceNov 23 10:29 ET

Guardant Health (GH) Set To Dominate The Growing Liquid Biopsy Market

Yahoo FinanceNov 22 14:21 ET

Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness

Seeking AlphaNov 15 15:55 ET